[Cardiovascular risk: a class effect of coxibs? How to manage patients taking Vioxx?].
Brune
K
K
Zacher
J
J
D003111:Colonic Polyps / Q000517:prevention & control; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D005858:Germany; D006801:Humans; D007783:Lactones / Q000008:administration & dosage / Q000009:adverse effects*; D008134:Long-Term Care; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000453:epidemiology; D010146:Pain / Q000188:drug therapy; D011358:Product Surveillance, Postmarketing; D012306:Risk; D013450:Sulfones / Q000008:administration & dosage / Q000009:adverse effects*
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib